PAVmed (PAVM) Share-based Compensation (2016 - 2025)
PAVmed's (PAVM) quarterly Share-based Compensation came in at $232000.0 in Q4 2025, down 68.35% year-on-year from $733000.0 in Q4 2024, and down 38.13% quarter-over-quarter from $375000.0 in Q3 2025.
PAVmed (PAVM) Share-based Compensation (2016 - 2025) Analysis & Trends
PAVmed's Share-based Compensation history runs 10 years deep, the most recent figure standing at $232000.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation fell 68.35% year-over-year to $232000.0 in Q4 2025; TTM through Dec 2025 was $1.5 million, a 67.06% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 73.53% from the prior year.
- Share-based Compensation eased to $232000.0 in Q4 2025 per PAVM's latest filing, from $375000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.2 million in Q2 2021 and bottomed at -$8.9 million in Q4 2022.
- The 5-year median for Share-based Compensation is $989000.0 (2023), against an average of $699052.6.
- Biggest YoY gain for Share-based Compensation was 883.55% in 2021; the steepest drop was 1015.61% in 2021.
- Year by year, Share-based Compensation stood at -$5.2 million in 2021, then sank by 70.86% to -$8.9 million in 2022, then soared by 111.09% to $989000.0 in 2023, then declined by 25.88% to $733000.0 in 2024, then sank by 68.35% to $232000.0 in 2025.
- Per Business Quant, the three latest PAVM Share-based Compensation figures stand at $232000.0 (Q4 2025), $375000.0 (Q3 2025), and $162000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 35.12 Mn |
| 10 | PAVmed | 10.85 Mn | 9.31 Mn | -4,000.00 | 232,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 232,000.00 |
| Dec 31, 2025 | 232,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | 162,000.00 |
| Jun 30, 2025 | 162,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Mar 31, 2025 | 241,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 934,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 989,000.00 |
| Dec 31, 2023 | 989,000.00 |
| Sep 30, 2023 | 2.25 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.09 Mn |